The consumer price index increased 7.7% year over year in October, a solid signal that the inflation rate is now trending in the right direction. The pharma stock Eli Lilly (NYSE: LLY) is chief among these stocks. Let's take a look under the hood at Eli Lilly's fundamentals and valuation to decide.
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Biotech giant Bristol Myers (BMY) outperforms the industry and the S&P 500 Index as Eliquis and Opdivo maintain momentum despite generic competition for Revlimid.